Published in West J Med on March 01, 1989
Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies. Clin Microbiol Rev (2005) 6.02
Unpredictable adverse reactions. West J Med (1989) 0.75
Mouse Protection Tests in the Study of Pertussis Vaccine: A Comparative Series Using the Intracerebral Route for Challenge. Am J Public Health Nations Health (1947) 15.54
Pertussis immunisation and serious acute neurological illness in children. Br Med J (Clin Res Ed) (1981) 8.48
Virulence factors of Bordetella pertussis. Annu Rev Microbiol (1986) 6.41
Pertussis toxin gene: nucleotide sequence and genetic organization. Science (1986) 6.02
Cloning and sequencing of the pertussis toxin genes: operon structure and gene duplication. Proc Natl Acad Sci U S A (1986) 5.59
Progress Report on Pertussis Immunization. Am J Public Health Nations Health (1936) 5.50
Neurological sequelae of prophylactic inoculation. Q J Med (1954) 4.43
Characterization of two adhesins of Bordetella pertussis for human ciliated respiratory-epithelial cells. J Infect Dis (1985) 3.66
EPIDEMIOLOGY OF A SMALL PERTUSSIS OUTBREAK IN KENT COUNTY, MICHIGAN. Public Health Rep (1965) 3.51
Pertussis vaccination. Dev Med Child Neurol (1974) 3.26
A 7-year survey of disorders attributed to vaccination in North West Thames region. Lancet (1983) 3.15
Role of antibody to leukocytosis-promoting factor hemagglutinin and to filamentous hemagglutinin in immunity to pertussis. Infect Immun (1981) 2.77
The concept of pertussis as a toxin-mediated disease. Pediatr Infect Dis (1984) 2.45
Epidemiological evaluation of immunisation and other factors in the control of whooping-cough. Lancet (1976) 2.29
DTP-associated reactions: an analysis by injection site, manufacturer, prior reactions, and dose. Pediatrics (1984) 2.15
The recurrence of whooping cough: possible implications for assessment of vaccine efficacy. Lancet (1982) 2.05
Is Universal Vaccination Against Pertussis Always Justified? Br Med J (1960) 1.93
The carrier state in pertussis. Am J Epidemiol (1968) 1.86
Whooping cough and its epidemiological anomalies. Am J Med Sci (1951) 1.85
The epidemiology of pertussis and pertussis immunization in the United Kingdom and the United States: a comparative study. Curr Probl Pediatr (1984) 1.81
Serological response to filamentous hemagglutinin and lymphocytosis-promoting toxin of Bordetella pertussis. Infect Immun (1983) 1.77
Cloning of the filamentous hemagglutinin of Bordetella pertussis and its expression in Escherichia coli. Infect Immun (1987) 1.69
Infants and children with convulsions and hypotonic-hyporesponsive episodes following diphtheria-tetanus-pertussis immunization: follow-up evaluation. Pediatrics (1988) 1.66
Spread of pertussis by hospital staff. JAMA (1972) 1.64
Neurological complications of pertussis immunization. Br Med J (1958) 1.64
Pertussis in adults. Ann Intern Med (1968) 1.61
The changing epidemiology of pertussis in young infants. The role of adults as reservoirs of infection. Am J Dis Child (1978) 1.54
Pertussis in Sweden after the cessation of general immunization in 1979. Pediatr Infect Dis J (1987) 1.41
Complications of immunization. Br Med J (1960) 1.25
Infantile spasms and early immunization against whooping cough. Danish survey from 1970 to 1975. Arch Dis Child (1977) 1.24
Possible temporal association between diphtheria-tetanus toxoid-pertussis vaccination and sudden infant death syndrome. Pediatr Infect Dis (1983) 1.23
Pertussis vaccine and whooping cough as risk factors in acute neurological illness and death in young children. Dev Biol Stand (1985) 1.21
The epidemiological evaluation of a non-cellular pertussis antigen. Pediatrics (1955) 1.17
Antitoxin antibody levels and the outcome of illness during an outbreak of diphtheria among alcoholics. Scand J Infect Dis (1986) 1.09
Immunization and cot deaths. Lancet (1982) 1.08
Further experience of reactions, especially of a cerebral nature, in conjunction with triple vaccination: a study based on vaccinations in Sweden 1959-65. Br Med J (1967) 1.08
Acellular and whole-cell pertussis vaccines in Japan. Report of a visit by US scientists. JAMA (1987) 1.06
Whooping cough in adults. Br Med J (Clin Res Ed) (1981) 1.02
An evaluation of pertussis vaccine. Rev Infect Dis (1980) 1.01
Infantile spasms and pertussis immunisation. Lancet (1983) 1.01
Soluble protective antigen from Bordetella pertussis prepared with sodium desoxycholate. J Immunol (1963) 0.99
Pertussis in the adult. Annu Rev Med (1977) 0.94
Acellular pertussis vaccine in adults: adverse reactions and immune response. Eur J Clin Microbiol (1987) 0.91
DTP and SIDS. Pediatr Infect Dis (1984) 0.89
Effects of islet-activating protein (IAP) on blood glucose and plasma insulin in healthy volunteers (phase 1 studies). Tohoku J Exp Med (1980) 0.88
Encephalopathies following prophylactic pertussis vaccine. Pediatrics (1948) 0.88
Recurrent seizures after diphtheria, tetanus, and pertussis immunization. Cause and effect v temporal association. Am J Dis Child (1984) 0.81
Pertussis surveillance, 1979-1981. MMWR Morb Mortal Wkly Rep (1982) 0.80
Selective primary health care: strategies for control of disease in the developing world. XVII. Pertussis and diphtheria. Rev Infect Dis (1985) 0.80
Pertussis--United States, 1982 and 1983. MMWR Morb Mortal Wkly Rep (1984) 0.79
Judge "not satisfied" that whooping cough vaccine causes permanent brain damage. Br Med J (Clin Res Ed) (1988) 0.77
Annual summary 1981. Reported morbidity & mortality in the United States. MMWR Morb Mortal Wkly Rep (1982) 0.77
Nosocomial pertussis: possible spread by a hospital visitor. Am J Dis Child (1980) 0.77
DTP vaccine reactions: effect of prior reactions on rate of subsequent reactions. Dev Biol Stand (1985) 0.77
Nature and rates of adverse reactions associated with DTP and DT immunizations in infants and children. Pediatrics (1981) 7.58
Transmission of hepatitis B virus to multiple patients from a surgeon without evidence of inadequate infection control. N Engl J Med (1996) 4.71
Soluble adenylate cyclase from the culture medium of Bordetella pertussis: purification and characterization. J Bacteriol (1976) 2.95
Treatment of first episodes of genital herpes simplex virus infection with oral acyclovir. A randomized double-blind controlled trial in normal subjects. N Engl J Med (1983) 2.91
Implementation of clinical guidelines using a computer charting system. Effect on the initial care of health care workers exposed to body fluids. JAMA (1997) 2.83
Large-quantity production of chicken embryo tracheal organ cultures and use in virus and mycoplasma studies. Appl Microbiol (1970) 2.54
Elevated cord macroglobulins in the diagnosis of intrauterine infections. N Engl J Med (1966) 2.50
Haemophilus influenzae meningitis. A national study of secondary spread in household contacts. N Engl J Med (1979) 2.34
Epidemic measles in young adults. Clinical, epidemiologic, and serologic studies. Ann Intern Med (1979) 2.29
Pertussis in adults. Ann Intern Med (1998) 2.25
Urban measles in the vaccine era: a clinical, epidemiologic, and serologic study. J Pediatr (1972) 2.24
Sales of nonprescription cold remedies: a unique method of influenza surveillance. Pediatr Res (1979) 2.22
Bacterial meningitis and septicemia in sickle cell disease. Am J Dis Child (1977) 2.19
DTP-associated reactions: an analysis by injection site, manufacturer, prior reactions, and dose. Pediatrics (1984) 2.15
Pulse oximetry as a fifth pediatric vital sign. Pediatrics (1997) 2.11
The 'new' epidemiology of measles and rubella. Hosp Pract (1980) 2.07
Clinical characteristics of illness caused by Bordetella parapertussis compared with illness caused by Bordetella pertussis. Pediatr Infect Dis J (1994) 1.90
Efficacy of cervical spine immobilization methods. J Trauma (1983) 1.89
Antibody responses to Bordetella pertussis antigens and clinical correlations in elderly community residents. Clin Infect Dis (2000) 1.85
A comparative efficacy trial in Germany in infants who received either the Lederle/Takeda acellular pertussis component DTP (DTaP) vaccine, the Lederle whole-cell component DTP vaccine, or DT vaccine. Pediatrics (1998) 1.84
A search for Bordetella pertussis infection in university students. Clin Infect Dis (1992) 1.83
The epidemiology of pertussis and pertussis immunization in the United Kingdom and the United States: a comparative study. Curr Probl Pediatr (1984) 1.81
Serological response to filamentous hemagglutinin and lymphocytosis-promoting toxin of Bordetella pertussis. Infect Immun (1983) 1.77
Immunologic response to early and routine DTP immunization in infants. Pediatrics (1984) 1.71
Pertussis in German adults. Clin Infect Dis (1995) 1.68
Infants and children with convulsions and hypotonic-hyporesponsive episodes following diphtheria-tetanus-pertussis immunization: follow-up evaluation. Pediatrics (1988) 1.66
Frequency of unrecognized Bordetella pertussis infections in adults. Clin Infect Dis (1995) 1.59
Admission decisions in emergency department chest pain patients at low risk for myocardial infarction: patient versus physician preferences. Ann Emerg Med (1996) 1.58
'Pertussis vaccine encephalopathy': it is time to recognize it as the myth that it is. JAMA (1990) 1.55
Bacterial-viral interrelations in respiratory infections of children. N Engl J Med (1967) 1.53
A comparison of pulse oximetry and respiratory rate in patient screening. Respir Med (1996) 1.51
The risk of Guillain-Barré syndrome after tetanus-toxoid-containing vaccines in adults and children in the United States. Am J Public Health (1997) 1.50
Severe reactions associated with diphtheria-tetanus-pertussis vaccine: detailed study of children with seizures, hypotonic-hyporesponsive episodes, high fevers, and persistent crying. Pediatrics (1993) 1.49
HL-A antigens and antibody response after influenza A vaccination. Decreased response associated with HL-A type W16. N Engl J Med (1976) 1.49
Lack of significant person-to-person spread of swine influenza-like virus following fatal infection in an immunocompromised child. Am J Epidemiol (1984) 1.47
Incorporating patient preferences into practice guidelines: management of children with fever without source. Ann Emerg Med (1994) 1.44
Erythema migrans after ceftriaxone treatment of aseptic meningitis caused by Borrelia burgdorferi. Pediatr Infect Dis J (2001) 1.43
The role of antibiotics, immunizations, and adenoviruses in pertussis. Pediatrics (1978) 1.42
Acute fever and petechial rash associated with influenza A virus infection. Clin Infect Dis (1999) 1.41
Capillary refill--is it a useful predictor of hypovolemic states? Ann Emerg Med (1991) 1.41
Mycoplasma pneumoniae infections and exanthems. J Pediatr (1975) 1.39
Care of the febrile child: an annotated bibliography. Am J Emerg Med (1991) 1.38
Household contact study of Bordetella pertussis infections. Clin Infect Dis (1995) 1.35
The evaluation of racemic epinephrine in the treatment of infectious croup. Pediatrics (1973) 1.33
Improved method for collection of nasal mucus. J Infect Dis (1977) 1.31
Pertussis toxin is required for pertussis vaccine encephalopathy. Proc Natl Acad Sci U S A (1985) 1.31
Hemorrhage from cecal ulcers of cytomegalovirus infection: report of a case. Ann Surg (1973) 1.30
Phosphatidylinositol-glycan anchors of membrane proteins: potential precursors of insulin mediators. Science (1988) 1.30
Bordetella pertussis infections and sudden unexpected deaths in children. Eur J Pediatr (1996) 1.29
Therapy of Haemophilus influenzae meningitis reconsidered. N Engl J Med (1972) 1.27
Pertussis caused by an erythromycin-resistant strain of Bordetella pertussis. Pediatr Infect Dis J (1995) 1.26
A prospective search for congenital dermal abnormalities of the craniospinal axis. J Pediatr (1975) 1.23
Possible temporal association between diphtheria-tetanus toxoid-pertussis vaccination and sudden infant death syndrome. Pediatr Infect Dis (1983) 1.23
Measles revaccination. Persistence and degree of antibody titer by type of immune response. Am J Dis Child (1978) 1.22
Advance directives. Effect of type of directive on physicians' therapeutic decisions. Arch Intern Med (1993) 1.22
Failure of cefamandole in treatment of meningitis due to Haemophilus influenzae type b. J Infect Dis (1978) 1.22
A clinical and serologic study of 103 children with measles vaccine failure. J Pediatr (1973) 1.21
Influence of parental knowledge and opinions on 12-month diphtheria, tetanus, and pertussis vaccination rates. Am J Dis Child (1988) 1.20
Effect of emergency department information on patient satisfaction. Ann Emerg Med (1993) 1.19
Distinct mechanisms for K+ efflux, intoxication, and hemolysis by Bordetella pertussis AC toxin. J Biol Chem (1998) 1.19
Atypical measles in children previously immunized with attenuated measles virus vaccines. Pediatrics (1972) 1.18
Polymerase chain reaction identification of Bordetella pertussis infections in vaccinees and family members in a pertussis vaccine efficacy trial in Germany. Pediatr Infect Dis J (1995) 1.17
Antibodies against measles virus polypeptides in different disease conditions. Infect Immun (1981) 1.16
Frequency of serological evidence of Bordetella infections and mixed infections with other respiratory pathogens in university students with cough illnesses. Clin Infect Dis (2000) 1.13
Human rabies. West J Med (1978) 1.12
Persistent cytomegalovirus infection of semen increases risk of AIDS. J Infect Dis (1994) 1.11
Implementation of clinical guidelines via a computer charting system: effect on the care of febrile children less than three years of age. J Am Med Inform Assoc (2000) 1.11
Exposure of emergency medicine personnel to ionizing radiation during cervical spine radiography. Ann Emerg Med (1989) 1.09
Typical, modified, and atypical measles. Arch Intern Med (1977) 1.09
Ultrastructure of Cowdry type A inclusions. 1. In human herpes simplex encephalitis. Neurology (1967) 1.09
A longitudinal study of cytomegalovirus infection in human immunodeficiency virus type 1-seropositive homosexual men: molecular epidemiology and association with disease progression. J Infect Dis (1994) 1.09
Rubella immunity in older children, teenagers, and young adults: a comparison of immunity in those previously immunized with those unimmunized. J Pediatr (1982) 1.09
The effect of prophylactic acetaminophen administration on reactions to DTP vaccination. Am J Dis Child (1988) 1.09
Clinical and serologic study of four smallpox vaccines comparing variations of dose and route of administration. Standard percutaneous revaccination of children who receive primary percutaneous vaccination. J Infect Dis (1977) 1.08
Effect of timing of measles vaccination on compliance with immunizations during the second year of life. J Pediatr (1983) 1.08
Penetration of cefamandole into spinal fluid. Antimicrob Agents Chemother (1977) 1.08
Risk of infection associated with the use of Broviac and Hickman catheters. Am J Infect Control (1982) 1.07
Epidemiology of Guillain-Barré syndrome in children: relationship of oral polio vaccine administration to occurrence. J Pediatr (1994) 1.07
Prolonged afebrile nonproductive cough illnesses in American soldiers in Korea: a serological search for causation. Clin Infect Dis (2000) 1.06
Clinical and serologic study of four smallpox vaccines comparing variations of dose and route of administration. Primary percutaneous vaccination. J Infect Dis (1977) 1.05
Effect of routine emergency department triage pulse oximetry screening on medical management. Chest (1995) 1.05
Clinical and antibody responses after influenza immunization in systemic lupus erythematosus. Ann Intern Med (1978) 1.03
Serious pertussis overlooked in infants. Eur J Pediatr (1992) 1.03
Clinical reactions and serologic responses after vaccination with whole-virus or split-virus influenza vaccines in children aged 6 to 36 months. Pediatrics (1982) 1.03
Need and desire for preventive care measures in emergency department patients. Ann Emerg Med (1995) 1.02
Failure of the mandatory domestic violence reporting law to increase medical facility referral to police. Ann Emerg Med (1998) 1.02
Analysis of proteins encoded by the ptx and ptl genes of Bordetella bronchiseptica and Bordetella parapertussis. Infect Immun (1996) 0.99
Clinical findings in Bordetella pertussis infections: results of a prospective multicenter surveillance study. Pediatrics (1997) 0.98
The treatment of croup: continued controversy due to failure of recognition of historic, ecologic, etiologic and clinical perspectives. J Pediatr (1979) 0.98
Comparative study of Lederle/Takeda acellular and Lederle whole-cell pertussis-component diphtheria-tetanus-pertussis vaccines in infants in Germany. Vaccine (1994) 0.97
Clinical validation of a polymerase chain reaction assay for the diagnosis of pertussis by comparison with serology, culture, and symptoms during a large pertussis vaccine efficacy trial. Pediatrics (2000) 0.97
Meningococcal endophthalmitis without concomitant septicemia or meningitis. Pediatr Infect Dis J (1989) 0.96
Selective regulation by pertussis toxin of insulin-induced activation of particulate cAMP phosphodiesterase activity in 3T3-L1 adipocytes. Biochem Biophys Res Commun (1983) 0.96
Pulse oximetry as a fifth vital sign in emergency geriatric assessment. Acad Emerg Med (1998) 0.96
Search for perinatal viral infection. A prospective, clinical, virologic, and serologic study. Am J Dis Child (1968) 0.95